Related Experiment Videos
Expression levels of protein kinase C-alpha in non-small-cell lung cancer
Michael Lahn1, Chen Su, Shuyu Li
1Oncology Product Development, Eli Lilly and Company, Indianapolis, IN 46285, USA. mlahn@lilly.com
Abstract:
Current treatments of non-small-cell lung cancer (NSCLC) are inadequate and new therapies are being developed that target specific cellular signaling proteins associated with tumor growth. One potential target is protein kinase C (PKC)-alpha, a signaling molecule with an important role in cell regulation and proliferation. The present study examines the expression levels of PKC-alpha in NSCLC to better understand the distribution of PKC-alpha in NSCLC. We analyzed tumor specimens from an independent tumor tissue bank to determine PKC-alpha protein and messenger RNA gene expression in NSCLC. In addition, we used publicly available gene expression array data to further understand PKC-a-associated gene expression profiles in NSCLC. We found that PKC-alpha is highly expressed in < or = 20% of patients with NSCLC. We also found that PKC-alpha was preferentially expressed in adenocarcinoma compared with squamous cell carcinoma of the lung.
Insights
Protein kinase C (PKC)-alpha is highly expressed in less than 20% of non-small-cell lung cancer (NSCLC) patients. This signaling protein is more prevalent in adenocarcinoma than squamous cell carcinoma.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Current non-small-cell lung cancer (NSCLC) treatments are insufficient.
- Targeting specific cellular signaling proteins is a promising therapeutic strategy.
- Protein kinase C (PKC)-alpha plays a role in cell regulation and proliferation.
Purpose of the Study:
- To investigate the expression levels and distribution of PKC-alpha in NSCLC.
- To identify PKC-alpha as a potential therapeutic target in NSCLC.
Main Methods:
- Analysis of tumor specimens from a tissue bank.
- Determination of PKC-alpha protein and messenger RNA (mRNA) gene expression.
- Utilized publicly available gene expression array data for further analysis.
Main Results:
- PKC-alpha was highly expressed in 20% or fewer of NSCLC patients.
- PKC-alpha demonstrated preferential expression in lung adenocarcinoma compared to squamous cell carcinoma.
Conclusions:
- PKC-alpha expression is limited in NSCLC, suggesting it may be a target for a subset of patients.
- The differential expression between adenocarcinoma and squamous cell carcinoma warrants further investigation for targeted therapies.
